Your browser doesn't support javascript.
loading
Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway.
Heo, Yu-Jung; Lee, Nami; Choi, Sung-E; Jeon, Ja-Young; Han, Seung-Jin; Kim, Dae-Jung; Kang, Yup; Lee, Kwan-Woo; Kim, Hae-Jin.
Afiliação
  • Heo YJ; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon 16499, Korea.
  • Lee N; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon 16499, Korea.
  • Choi SE; Department of Physiology, Ajou University School of Medicine, Suwon 16499, Korea.
  • Jeon JY; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon 16499, Korea.
  • Han SJ; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon 16499, Korea.
  • Kim DJ; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon 16499, Korea.
  • Kang Y; Department of Physiology, Ajou University School of Medicine, Suwon 16499, Korea.
  • Lee KW; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon 16499, Korea.
  • Kim HJ; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon 16499, Korea.
Biomedicines ; 10(5)2022 Apr 29.
Article em En | MEDLINE | ID: mdl-35625768
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2022 Tipo de documento: Article